REGN : Regeneron Pharmaceuticals stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)
| subject | Average | Low | High | Change from close on 2021-06-15 |
|---|---|---|---|---|
| REGN : Regeneron Pharmaceuticals stock forecast | $632.67 | $525.0 | $760.0 | 19.94% |
| REGN : Regeneron Pharmaceuticals stock forecast 2021 | $573.45 | $524.07 | $625.38 | 8.71% |
| REGN : Regeneron Pharmaceuticals stock forecast 2022 | $628.3 | $524.3 | $697.21 | 19.11% |
| REGN : Regeneron Pharmaceuticals stock forecast 2023 | $660.27 | $515.99 | $967.07 | 25.17% |
| REGN : Regeneron Pharmaceuticals stock forecast 2024 | $1402.09 | $1228.22 | $1620.58 | 165.8% |
| REGN : Regeneron Pharmaceuticals stock forecast 2025 | $868.43 | $692.25 | $1150.61 | 64.63% |
| REGN : Regeneron Pharmaceuticals stock forecast 2026 | $723.2 | $678.54 | $753.74 | 37.1% |
| REGN : Regeneron Pharmaceuticals stock forecast 2027 | $643.49 | $596.7 | $678.77 | 21.99% |
| REGN : Regeneron Pharmaceuticals stock forecast 2028 | $945.65 | $598.24 | $1656.01 | 79.27% |
| REGN : Regeneron Pharmaceuticals stock forecast 2029 | $1220.44 | $706.6 | $1628.36 | 131.37% |
| REGN : Regeneron Pharmaceuticals stock forecast 2030 | $721.84 | $687.37 | $772.31 | 36.84% |
| REGN : Regeneron Pharmaceuticals stock forecast 2031 | $687.92 | $671.15 | $698.51 | 30.41% |
The 15 Wall Street analysts offering Regeneron Pharmaceuticals stock forecast in the last 6 months have average price target of
$632.67 with a high forecast of $760.0 and a low forecast of $525.0.
The average Regeneron Pharmaceuticals stock forecast represents a 19.94%
increase from the last price of $527.49.
Our research supports the forecast. According to our research,
Cash Ratio forecast is 0.58325250929869.
It is -24.41% from the last annual Cash Ratio report of 0.771630258513784.
EPS forecast is 0.58325250929869.
It is increase 52.17% from the last annual EPS report of 18.4625.
Sales Per Share forecast is 0.58325250929869.
It is increase 79.74% from the last annual Sales Per Share report of 68.6161.
From AI system, total return is 2166.92% from 1914 forecasts.
For Regeneron Pharmaceuticals stock forecast 2021, 6 predictions are offered for each month of 2021 with average Regeneron Pharmaceuticals stock
forecast of $573.45, a high forecast of $625.38, and a low forecast of $524.07.
The average Regeneron Pharmaceuticals stock forecast 2021 represents a 8.71%
increase from the last price of $527.49.
For Regeneron Pharmaceuticals stock forecast 2022, 12 predictions are offered for each month of 2022 with average Regeneron Pharmaceuticals stock
forecast of $628.3, a high forecast of $697.21, and a low forecast of $524.3.
The average Regeneron Pharmaceuticals stock forecast 2022 represents a 19.11%
increase from the last price of $527.49.
For Regeneron Pharmaceuticals stock forecast 2025, 12 predictions are offered for each month of 2025 with average Regeneron Pharmaceuticals stock
forecast of $868.43, a high forecast of $1150.61, and a low forecast of $692.25.
The average Regeneron Pharmaceuticals stock forecast 2025 represents a 64.63%
increase from the last price of $527.49.
For Regeneron Pharmaceuticals stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Regeneron Pharmaceuticals stock
forecast of $723.2, a high forecast of $753.74, and a low forecast of $678.54.
The average Regeneron Pharmaceuticals stock forecast 2026 represents a 37.1%
increase from the last price of $527.49.
For Regeneron Pharmaceuticals stock forecast 2030, 12 predictions are offered for each month of 2030 with average Regeneron Pharmaceuticals stock
forecast of $721.84, a high forecast of $772.31, and a low forecast of $687.37.
The average Regeneron Pharmaceuticals stock forecast 2030 represents a 36.84%
increase from the last price of $527.49.
For Regeneron Pharmaceuticals stock forecast 2031 (10 year), 6 predictions are offered for each month of 2031 with average Regeneron Pharmaceuticals stock
forecast of $687.92, a high forecast of $698.51, and a low forecast of $671.15.
The average Regeneron Pharmaceuticals stock forecast 2031 represents a 30.41%
increase from the last price of $527.49.
Please, see more forecasts below.
REGN : Regeneron Pharmaceuticals stock forecast Wall Street by analysts
The average Regeneron Pharmaceuticals stock forecast from last 6 month is $632.67, and this show a -2.4% decrease in average from the prior price target of the each prediction. Also, this average forecast of $632.67 represents a -5.05% decrease from the past average forecast of $666.35, 6 months ago from 17 wall street analysts.
Regeneron Pharmaceuticals stock forecast for upcoming days
Long term Regeneron Pharmaceuticals (REGN) stock forecast for 2021, 2022 (1 year) - 2025, 2026 (5 year) - 2030, and 2031 (10 year)
Forecast for Jul. 2021 is $524.07 , for Jun. 2022 is $657.04 , for Jun. 2025 is $924.93 , for Jun. 2026 is $738.15 , for Jun. 2030 is $707.75 , and for Jun. 2031 is $671.15.
REGN Cash Ratio forecast
Cash Ratio forecast for 2021 is 0.58325250929869, 2022 is 0.569470660961264, and 2023 is 0.500329570501341.
REGN EPS ( Earning Per Share ) forecast
EPS forecast for 2021 is 28.0943482790769, 2022 is 26.2674750051832, and 2023 is 28.5615434311406.
REGN Sales Per Share forecast
Sales Per Share forecast for 2021 is 123.331891442435, 2022 is 192.62155906731, and 2023 is 223.088884815484.
Financial Data for Regeneron Pharmaceuticals stock
Frequently Asked Questions about Regeneron Pharmaceuticals stock forecast
Is Regeneron Pharmaceuticals a good long term stock?
From Regeneron Pharmaceuticals stock forecast 2021, Regeneron Pharmaceuticals (REGN) stock cannot be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for Jul. 2021 is $524.072669853558 From Regeneron Pharmaceuticals stock forecast 2022, Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for Jun. 2022 is $657.044593046119 From Regeneron Pharmaceuticals stock forecast 2025, Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for Jun. 2025 is $924.928362092828 From Regeneron Pharmaceuticals stock forecast 2026, Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for Jun. 2026 is $738.154202013509 From Regeneron Pharmaceuticals stock forecast 2030, Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for Jun. 2030 is $707.750798662111 From Regeneron Pharmaceuticals stock forecast 2031, Regeneron Pharmaceuticals (REGN) stock can be a good investment choice. According to AI Pickup, the Regeneron Pharmaceuticals stock price forecast for Jun. 2031 is $671.150376667184
Is Regeneron Pharmaceuticals stock overvalued?
Regeneron Pharmaceuticals (REGN) stock is expected to go UP . Therefore, AI Pickup would say that Regeneron Pharmaceuticals (REGN) stock is NOT overvalued.
Will Regeneron Pharmaceuticals stock price go up?
Yes. The Regeneron Pharmaceuticals stock price forecast for Jun. 2022 is $657.044593046119
Is Regeneron Pharmaceuticals stock a good buy now?
Since closing price on 2021-06-15 is $527.49 and forecast for Jun. 2022 is $657.04, Regeneron Pharmaceuticals stock is a good 1 year investment.